Medicine for treating proliferation of mammary glands
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A breast hyperplasia and drug technology, applied in the field of medicine, can solve problems such as overcorrection, and achieve the effects of not easy recurrence, quick effect, and scientific and reasonable prescription
Inactive Publication Date: 2017-05-03
GUIZHOU HUAANTANG PHARMA CO LTD
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Western medicine treatment of mammary gland hyperplasia is to regulate ovarian endocrine or block hormone targets, block the pathogenesis, and relieve symptoms. Therefore, estrogen-suppressing drugs are often used in the treatment pla
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Example Embodiment
[0031] Embodiment 1 of the present invention: a kind of medicine for the treatment of hyperplasia of mammary gland, this medicine is made of the raw material of following weight composition ratio: 15 parts of Prunella vulgaris, 15 parts of Radix Curcuma, 10 parts of Buliuxing, 12 parts of safflower, 15 parts of Salvia miltiorrhiza 10 parts of saponins, 10 parts of licorice, 10 parts of angelica, 10 parts of red peony, 8 parts of Bupleurum, 15 parts of bergamot, 15 parts of anise, and 15 parts of cumin.
Example Embodiment
[0032] Embodiment 2 of the present invention: a kind of medicine for the treatment of mammary gland hyperplasia, this medicine is made of the raw materials of following weight composition ratio: 25 parts of Prunella vulgaris, 25 parts of Radix Curcuma, 20 parts of Wang Buliuxing, 20 parts of safflower, 25 parts of Salvia miltiorrhiza 18 parts of saponins, 20 parts of licorice, 18 parts of angelica, 16 parts of red peony, 16 parts of Bupleurum, 25 parts of bergamot, 25 parts of anise, and 25 parts of cumin.
Example Embodiment
[0033] Embodiment 3 of the present invention: a kind of medicine for the treatment of mammary gland hyperplasia, this medicine is made of the raw materials of following weight composition ratio: 20 parts of Prunella vulgaris, 20 parts of Curcuma curcuma, 16 parts of Wang Buliuxing, 16 parts of safflower, 20 parts of Salvia miltiorrhiza 14 parts of saponins, 15 parts of licorice, 14 parts of angelica, 14 parts of red peony, 12 parts of Bupleurum, 19 parts of bergamot, 20 parts of anise, and 20 parts of cumin.
[0034] When making the medicine of the above examples, mix the medicine, dry it, and pulverize it into a fine powder of about 100 mesh, add refined honey with a weight ratio of 1:1 to the medicine powder, mix evenly, make strips, and form pills at 5 g / pill , beeswax can be sealed.
[0035] Dosage: Take orally, once a day in the morning and evening, take one pill each time, take it with boiled water.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicine for treating proliferation of mammary glands. The medicine for treating proliferation of the mammary glands is prepared from the following components comprising, by weight, 15-25 parts of fruit spike of selfheal, 15-25 parts of radix curcumae, 10-20 parts of cowherb seeds, 12-20 parts of safflower, 15-25 parts of roots of red-rooted salvia, 10-18 parts of Chinese honeylocust spine, 10-20 parts of liquorice, 10-18 parts of Chinese angelica, 10-16 parts of red peony roots, 8-16 parts of red thorowax roots, 15-25 parts of fingered citron, 15-25 parts of anise and 15-25 parts of fennel. Clinical observation is conducted for years as follows, 100 patients of hyperplasia of the mammary glands are selected, after the 100 patients take the medicine for three months, the statistic result shows that 63 patients are clinically cured, the clinical curing rate is 63%, the medicine acts on 34 patients, the effective rate is 34%, and the medicine is ineffective on three patients; and detection results prove that the medicine is significantly effective after the patient takes the medicine for about 2 weeks, and symptoms disappear or are relieved after two months, the total effective rate is 97%, and relapse is not prone to happen.
Description
technical field [0001] The invention relates to a medicine for treating mammary gland hyperplasia, which belongs to the technical field of medicines. Background technique [0002] Breast hyperplasia is the most common breast disease in women, and its incidence rate accounts for the first place in breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age is getting younger and younger. In adolescent or young women, there is breast distending pain before menstruation, and sometimes the pain spreads to the shoulder and back. After menstruation, the breast pain gradually relieves itself, and only some thickening of the breast can be felt without obvious nodules. These are physiological changes, not The disease does not require treatment, and it is a physiological hyperplasia. Mammary gland hyperplasia is the physiological hyperplasia and incomplete involution of normal mammary gland lobules, and the normal structure of the mam...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more